Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    mrna-2416
Previous Study | Return to List | Next Study

Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03323398
Recruitment Status : Active, not recruiting
First Posted : October 27, 2017
Last Update Posted : August 16, 2021
Sponsor:
Information provided by (Responsible Party):
ModernaTX, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 20, 2022
Estimated Study Completion Date : September 20, 2022